HEPATOCELLULAR PROLIFERATION, TNF-ALPHA AND INFLAMMATION IN PRIMARY BILIARY-CIRRHOSIS (PBC)

被引:1
|
作者
FLOREANI, A [1 ]
INFANTOLINO, D [1 ]
DELAZZARI, F [1 ]
BIASIN, MR [1 ]
VENTURI, C [1 ]
ZAPPALA, F [1 ]
CHIARAMONTE, M [1 ]
NACCARATO, R [1 ]
机构
[1] CASTELFRANCO VENETO HOSP,DEPT PATHOL,I-33143 CASTELFRANCO VENE,ITALY
来源
关键词
PROLIFERATION; TNF-ALPHA; PRIMARY BILIARY CIRRHOSIS;
D O I
10.1016/0928-4346(94)90077-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aims of this study were to investigate the rate of hepatocellular proliferation in PBC and its correlation with the site of inflammation and serum TNFalpha levels. Hepatic proliferation was evaluated in liver sections from 11 patients with PBC (two histological stage II, eight stage III, one stage IV) using the indirect immunoperoxidase technique with a monoclonal antibody against proliferating cell nuclear antigen (PCNA). Counter-staining with hematoxylin was performed and at least 500 nuclei were counted by two observers who blindly calculated the site of positive cells (perivenular, periportal/periseptal). The percentage of hepatocytes expressing PCNA was significantly higher in the periportal/periseptal regions than in the perivenular area (70 +/- 5.8% vs. 36 +/- 6.9%, P < 0.002). Hepatocellular PCNA expression in the periportal/periseptal (portal area) correlated with TNFalpha serum levels (r = 0.8, P < 0.03). In conclusion, hepatocellular proliferation in PBC significantly correlates with the site of inflammation and serum levels of TNFalpha. This data seems to confirm that inflammation and cytokines may stimulate hepatocyte DNA synthesis.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 50 条
  • [31] PRIMARY BILIARY-CIRRHOSIS (PBC) SURVIVAL MODEL IN MEXICAN PATIENTS
    RODRIGUEZLEAL, G
    MARINLOPEZ, E
    GONZALEZ, M
    MORALES, L
    LISKERMELMAN, M
    KERSHENOBICH, D
    VARGAS, F
    HEPATOLOGY, 1993, 18 (04) : A218 - A218
  • [32] IMPAIRED ANTIPYRINE CLEARANCE IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS (PBC)
    VONMOLTKE, L
    ABERNETHY, DR
    KAPLAN, MM
    GREENBLATT, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 173 - 173
  • [33] THE CAUSE OF ZINC DEPLETION IN THE LIVER IN PRIMARY BILIARY-CIRRHOSIS (PBC)
    JANSSENS, AR
    BIEMOND, I
    VANDENHAMER, CJA
    NETHERLANDS JOURNAL OF MEDICINE, 1986, 29 (08): : 262 - 262
  • [34] PRIMARY BILIARY-CIRRHOSIS (PBC) - IS EFFECTIVE THERAPY NOW AT HAND
    KAPLAN, MM
    KNOX, TA
    ARORA, S
    CLINICAL RESEARCH, 1988, 36 (03): : A610 - A610
  • [35] SYMPTOM DEVELOPMENT AND PROGNOSIS IN ASYMPTOMATIC PRIMARY BILIARY-CIRRHOSIS (PBC)
    MITCHISON, H
    KELLY, P
    NEUBERGER, J
    BASSENDINE, M
    WILLIAMS, R
    JAMES, O
    GUT, 1988, 29 (10) : A1431 - A1432
  • [36] CIRCULATING IMMUNE-COMPLEXES IN PRIMARY BILIARY-CIRRHOSIS (PBC)
    SANDILANDS, GP
    GALBRAITH, I
    REID, FM
    MILLS, P
    MACSWEEN, RNM
    JOURNAL OF PATHOLOGY, 1980, 131 (03): : 273 - 273
  • [37] CYCLOSPORINE A INHIBITS LYMPHOKINE PRODUCTION IN PRIMARY BILIARY-CIRRHOSIS (PBC)
    ANASTASSAKOS, C
    ALEXANDER, GJM
    EDDLESTON, ALWF
    WILLIAMS, R
    JOURNAL OF HEPATOLOGY, 1987, 5 : S3 - S3
  • [38] DEFECTIVE RADIOCOPPER INCORPORATION IN EARLY PRIMARY BILIARY-CIRRHOSIS (PBC)
    HAMLYN, AN
    HEPPLE, M
    MACKLON, AM
    HAGGITH, JW
    JAMES, O
    GUT, 1980, 21 (10) : A899 - A899
  • [39] TUBULOINTERSTITIAL DISORDERS IN THE KIDNEY ASSOCIATED WITH PRIMARY BILIARY-CIRRHOSIS (PBC)
    KAMOUCHI, M
    TSUJI, H
    HIRAKATA, H
    OKAMURA, K
    ISHITSUKA, T
    MURAI, K
    ONOYAMA, K
    FUJISHIMA, M
    CLINICAL NEPHROLOGY, 1991, 35 (03) : 134 - 135
  • [40] EOSINOPHILIA IN PRIMARY BILIARY-CIRRHOSIS (PBC) - A HITHERTO UNRECOGNIZED FEATURE
    YAMAZAKI, K
    ABE, S
    NAKADATE, I
    SUZUKI, K
    SATO, S
    HEPATOLOGY, 1992, 16 (04) : A194 - A194